Literature DB >> 17234734

Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.

Laurent D Vallat1, Yuhyun Park, Cheng Li, John G Gribben.   

Abstract

Gene expression in cells is a dynamic process but is usually examined at a single time point. We used gene expression profiling over time to build temporal models of gene transcription after B-cell receptor (BCR) signaling in healthy and malignant B cells and chose this as a model since BCR cross-linking induces both cell proliferation and apoptosis, with increased apoptosis in chronic lymphocytic leukemia (CLL) compared to healthy B cells. To determine the basis for this, we examined the global temporal gene expression profile for BCR stimulation and developed a linear combination method to summarize the effect of BCR simulation over all the time points for all patients. Functional learning identified common early events in healthy B cells and CLL cells. Although healthy and malignant B cells share a common genetic pattern early after BCR signaling, a specific genetic program is engaged by the malignant cells at later time points after BCR stimulation. These findings identify the molecular basis for the different functional consequences of BCR cross-linking in healthy and malignant B cells. Analysis of gene expression profiling over time may be used to identify genes that might be rational targets to perturb these pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234734      PMCID: PMC1874586          DOI: 10.1182/blood-2006-09-045377

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.

Authors:  Clair S Gricks; David Zahrieh; A Jason Zauls; Gullu Gorgun; Daniela Drandi; Katja Mauerer; Donna Neuberg; John G Gribben
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

2.  Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.

Authors:  Dirk Kienle; Axel Benner; Alexander Kröber; Dirk Winkler; Daniel Mertens; Andreas Bühler; Till Seiler; Ulrich Jäger; Peter Lichter; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

3.  Reverse engineering of regulatory networks in human B cells.

Authors:  Katia Basso; Adam A Margolin; Gustavo Stolovitzky; Ulf Klein; Riccardo Dalla-Favera; Andrea Califano
Journal:  Nat Genet       Date:  2005-03-20       Impact factor: 38.330

4.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

Authors:  U Klein; Y Tu; G A Stolovitzky; M Mattioli; G Cattoretti; H Husson; A Freedman; G Inghirami; L Cro; L Baldini; A Neri; A Califano; R Dalla-Favera
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

5.  Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.

Authors:  Dirk L Kienle; Christian Korz; Beate Hosch; Axel Benner; Daniel Mertens; Annett Habermann; Alexander Kröber; Ulrich Jäger; Peter Lichter; Hartmut Döhner; Stephan Stilgenbauer
Journal:  J Clin Oncol       Date:  2005-05-02       Impact factor: 44.544

6.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

7.  Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.

Authors:  S Zupo; R Massara; M Dono; E Rossi; F Malavasi; M E Cosulich; M Ferrarini
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

9.  Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.

Authors:  Katja Mauerer; David Zahrieh; Gullu Gorgun; Aihong Li; Jianbiao Zhou; Sascha Ansén; Laura Z Rassenti; John G Gribben
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

10.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  22 in total

1.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

2.  A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.

Authors:  Aurore Perrot; Cédric Pionneau; Sophie Nadaud; Frédéric Davi; Véronique Leblond; Frédéric Jacob; Hélène Merle-Béral; Raoul Herbrecht; Marie-Christine Béné; John G Gribben; Seiamak Bahram; Laurent Vallat
Journal:  Blood       Date:  2011-05-20       Impact factor: 22.113

3.  Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.

Authors:  Francesca Arruga; Valeria Bracciamà; Nicoletta Vitale; Tiziana Vaisitti; Katiuscia Gizzi; Alison Yeomans; Marta Coscia; Giovanni D'Arena; Gianluca Gaidano; John N Allan; Richard R Furman; Graham Packham; Francesco Forconi; Silvia Deaglio
Journal:  Leukemia       Date:  2019-08-29       Impact factor: 11.528

4.  Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia.

Authors:  Laurent Vallat; Corey A Kemper; Nicolas Jung; Myriam Maumy-Bertrand; Frédéric Bertrand; Nicolas Meyer; Arnaud Pocheville; John W Fisher; John G Gribben; Seiamak Bahram
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

Review 5.  α-Helical coiled-coil peptide materials for biomedical applications.

Authors:  Yaoying Wu; Joel H Collier
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-09-06

6.  Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Authors:  Te-Wei Chu; Jindřich Kopeček
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

7.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Authors:  Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter Munson; Wyndham H Wilson; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

8.  Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.

Authors:  Libin Zhang; Yixin Fang; Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2016-12-24       Impact factor: 9.776

9.  Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation.

Authors:  V H Cowling
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

10.  Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.

Authors:  Te-Wei Chu; Jiyuan Yang; Rui Zhang; Monika Sima; Jindřich Kopeček
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.